meningococcal A/B/C (North American)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemeningococcal A/B/C (North American)

Drug Alias Namemeningococcal A/C (North American Vaccine)meningococcal B/C/Y (North American Vaccine)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeisseriaceae Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNorth American Vaccine Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNorth American Vaccine Inc

Active IndicationsN/A

Inactive IndicationsNeisseriaceae Infections

Other Information

ATC CodeN/A